Protective effects of udenafil citrate, piracetam and dexmedetomidine treatment on testicular torsion/detorsion- induced ischaemia/reperfusion injury in rats
| dc.contributor.author | Tuglu, D. | |
| dc.contributor.author | Yuvanc, E. | |
| dc.contributor.author | Ozan, T. | |
| dc.contributor.author | Bal, F. | |
| dc.contributor.author | Yilmaz, E. | |
| dc.contributor.author | Atasoy, P. | |
| dc.contributor.author | Batislam, E. | |
| dc.date.accessioned | 2026-08-12T17:16:58Z | |
| dc.date.issued | 2016 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | The aim of this study was to investigate the antioxidant properties of udenafil citrate (1.4 mg kg(-1)-2.8 mg kg(-1)), dexmedetomidine 25 mu g kg(-1) and piracetam 200 mg kg(-1) administered on ipsilateral/contralateral testes after ischaemia in a rat model of testicular torsion/detorsion (T/D) and define its protective effect histologically. Fifty-six Wistar albino rats were included and randomly assigned into 6 groups. No intervention was performed in control group (Group 1, n = 8) and in torsion/detorsion group, (Group 2, n = 8). Udenafil 1.4 mg kg(-1) was given to torsion/detorsion group (Group 3, n = 10), udenafil 2.8 mg kg(-1) was given to torsion/detorsion group (Group 4, n = 10), piracetam 200 mg kg(-1) was given to torsion/detorsion group (Group 5, n = 10) and dexmedetomidine 25 mu g kg(-1) was given to torsion/detorsion group (Group 6, n = 10) intraperitoneally after 60 mins of testicular torsion. Biochemical and histopathological testicular injury were evaluated. When the tissue was examined by TOS values, Group 3, Group 4 and Group 5 were significantly lower than Group 2. In contrary Group 6 values were significantly higher than Group 2. The increasing doses of udenafil demonstrated antioxidant properties on the testis tissue and histopathological that protects the testicles. | |
| dc.identifier.doi | 10.1111/and.12499 | |
| dc.identifier.endpage | 682 | |
| dc.identifier.issn | 0303-4569 | |
| dc.identifier.issn | 1439-0272 | |
| dc.identifier.issue | 6 | |
| dc.identifier.orcid | 0000-0002-4595-6298 | |
| dc.identifier.orcid | 0000-0002-7493-4573 | |
| dc.identifier.orcid | 0000-0002-5822-6972 | |
| dc.identifier.orcid | 0000-0002-5603-8265 | |
| dc.identifier.pmid | 26589469 | |
| dc.identifier.scopus | 2-s2.0-84977532430 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 676 | |
| dc.identifier.uri | https://doi.org/10.1111/and.12499 | |
| dc.identifier.uri | https://hdl.handle.net/11508/52483 | |
| dc.identifier.volume | 48 | |
| dc.identifier.wos | WOS:000380894600010 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wiley-Blackwell | |
| dc.relation.ispartof | Andrologia | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Dexmedetomidine | |
| dc.subject | piracetam | |
| dc.subject | total antioxidant capacity (TAC) | |
| dc.subject | total oxidant status (TOS) | |
| dc.subject | udenafil | |
| dc.title | Protective effects of udenafil citrate, piracetam and dexmedetomidine treatment on testicular torsion/detorsion- induced ischaemia/reperfusion injury in rats | |
| dc.type | Article |







